Larvol Delta - Evaluate-the-Safety-and-Preliminary-Immunogenicity-of-a-SARSCoV2-mRNA-Vaccine-in-Adults

SARS-CoV-2 mRNA vaccine (RBMRNA) - Argorna Pharma

CoronaVac - Sinovac, Bio Farma Indonesia

http://clinicaltrials.gov/ct2/show/NCT05897190

Jun 9, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev